- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02855528
Tin Filter Calcium Scoring
July 31, 2018 updated by: Medical University of South Carolina
Ultra Low-dose Coronary Artery Calcium Scoring Using Tin Filtration With Dual-source CT
The aim of this study is to prospectively investigate the diagnostic performance and potential radiation dose reduction in coronary artery calcium scoring using the new tin filter system of the 3rd generation DSCT scanner.
Study Overview
Study Type
Interventional
Enrollment (Actual)
149
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject must be between 19-90 years of age.
- Subject must have been referred for a clinically indicated coronary artery calcium scan and/or coronary CT angiography or TRO scan with coronary artery calcium scoring.
- Subject must provide written informed consent prior to any study-related procedures being performed.
- Subject must be willing to comply with all clinical study procedures.
Exclusion Criteria:
- Subject is a pregnant or nursing female. Exclude the possibility of pregnancy:
- By testing (urine BHCG) within 24 hours before scan, or
- By surgical sterilization, or
- Post menopausal, with minimum one (1) year history without menses.
- Subject has an acute psychiatric disorder or is cognitively impaired.
- Subject is using or is dependent on substances of abuse.
- Subject is unwilling to comply with the requirements of the protocol.
- Subject is in acute unstable condition.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Reduction of radiation dose and diagnostic accuracy
Reduction of radiation dose during coronary artery calcium scoring with the use of a tin filter system.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction in radiation dose using the new tin-filter system
Time Frame: 2 years
|
2 years
|
Diagnostic accuracy of novel ultralow-dose non-enhanced coronary artery calcium scoring performed with the new tin filter system.
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joseph U. Schoepf, MD, Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (Actual)
November 14, 2017
Study Completion (Actual)
November 14, 2017
Study Registration Dates
First Submitted
July 28, 2016
First Submitted That Met QC Criteria
August 1, 2016
First Posted (Estimate)
August 4, 2016
Study Record Updates
Last Update Posted (Actual)
August 2, 2018
Last Update Submitted That Met QC Criteria
July 31, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- Pro00051523
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation Dose Reduction
-
Malmö UniversityCompletedLow-Dose CBCT Protocol for Pre-Surgical Evaluation of the Mandibular Third Molar, a Feasible Choice?Cone Beam Couputed Tomography, Dose ReductionSweden
-
Rambam Health Care CampusCompleted
-
Kaiser PermanenteUniversity of California, San FranciscoCompletedDecrease Variability and Amount of Radiation Dose From CT Exams
-
Pepperdine UniversityRecruitingHigh Nitrate Dose | Moderate Nitrate Dose | Low Nitrate Dose | Nitrate-depleted DoseUnited States
-
Tianjin Medical University Cancer Institute and...Completedthe Diffenence of Different Detector Row 4DCT,Especially in Artifects,Radiation Dose and Target VolumeChina
-
Asan Medical CenterRecruitingQuality of Life | Prostate Cancer | Radiation Toxicity | Biochemical Recurrence | Survival | Radiation | Hypofractionation | Dose EscalationKorea, Republic of
-
Northumbria UniversityCompletedLow Fat Meal - Unadjusted Insulin Dose | High Fat Meal - Unadjusted Insulin Dose | High Fat Meal - Adjusted Insulin Dose +30 Percent | High Fat Meal - Adjusted Insulin Dose +Split Dose
-
Fujian Akeylink Biotechnology Co., Ltd.The First Hospital of Jilin UniversityRecruitingPharmacokinetics | Food Affect | Single Ascending Dose | Maximum Applicable DoseChina
-
Chulalongkorn UniversityHIV-NAT, Thai Red Cross - AIDS Research Centre; Chula Clinical Research Center...RecruitingSafety of a Single Dose of COMVIGEN Vaccine | Reactogenicity of a Single Dose of COMVIGEN Vaccine | Immunogenicity of a Single Dose of COMVIGEN Vaccine | Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Immunogenicity...Thailand
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingPreoperative | Midazolam | DoseChina
Clinical Trials on Tin Filter
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedComplication of HemodialysisItaly
-
Aquora Research & Consulting, LLCSawyer Products, Inc; The Bucket Ministry; Sparrow Data SolutionsEnrolling by invitation
-
University of Southern CaliforniaDuke UniversityRecruiting
-
Johnson & Johnson Vision Care, Inc.CompletedPhotosensitivityUnited States
-
University of AarhusRhinix ApSCompletedSeasonal Allergic RhinitisDenmark
-
University of AarhusSpirare ApSCompletedRhinitis, Allergic, SeasonalDenmark
-
University of RochesterCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Masonic Cancer Center, University of MinnesotaOhio State UniversityActive, not recruiting
-
National Institute of Environmental Health Sciences...Completed
-
University of CadizRocío Martín Valero; Mª José Abellán Hervás; Ana María Sáinz OteroCompletedCardiovascular DiseasesSpain